Provided by Tiger Trade Technology Pte. Ltd.

Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)

8.35
+0.05000.60%
Post-market: 8.350.00000.00%16:15 EDT
Volume:640.34K
Turnover:5.30M
Market Cap:808.69M
PE:-4.28
High:8.57
Open:8.41
Low:8.10
Close:8.30
52wk High:11.06
52wk Low:3.30
Shares:96.85M
Float Shares:77.97M
Volume Ratio:1.10
T/O Rate:0.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9500
EPS(LYR):-2.5505
ROE:-74.65%
ROA:-42.51%
PB:3.22
PE(LYR):-3.27

Loading ...

Anteris Technologies’ director Stephen Denaro files initial beneficial ownership statement

Reuters
·
May 19

Initial Director's Interest Notice x 2-AVR.O

Reuters
·
May 18

Anteris Techs Glbl Is Maintained at Overweight by Barclays

Dow Jones
·
May 15

Anteris Technologies Global : Barclays Raises Target Price to $18 From $17

THOMSON REUTERS
·
May 15

Barclays Reaffirms Their Buy Rating on Anteris Technologies Global Corp. (AVR)

TIPRANKS
·
May 15

Anteris Technologies price target raised to $18 from $17 at Barclays

TIPRANKS
·
May 15

We Think Anteris Technologies Global (ASX:AVR) Can Afford To Drive Business Growth

Simply Wall St.
·
May 15

Anteris appoints Susan Knight, Stephen Denaro to board

Reuters
·
May 13

Anteris Appoints Susan Knight and Stephen Denaro to Its Board of Directors

THOMSON REUTERS
·
May 13

Press Release: Anteris Appoints Susan Knight and Stephen Denaro to its Board of Directors

Dow Jones
·
May 13

Anteris Technologies Global Corp-Board Appointments

THOMSON REUTERS
·
May 13

Board Appointments-AVR.O

Reuters
·
May 13

Anteris Technologies Global Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Anteris Announces Results for the First Quarter of 2026

THOMSON REUTERS
·
May 13

Anteris Technologies Glb Q1 EPS $(0.28) Misses $(0.27) Estimate, Sales $494.000K Miss $766.667K Estimate

Benzinga Earnings
·
May 13

Anteris Q1 FY26 loss widens 4% to $22.9 million; net sales fall 11% to $494,000

Reuters
·
May 13

Anteris Technologies Global Corp expected to post a loss of 15 cents a share - Earnings Preview

Reuters
·
May 08

BRIEF-Anteris Technologies Announces First U.S. Patients Treated In Global Pivotal Paradigm Trial

Reuters
·
May 05

Anteris enrolls first US patients in DurAVR PARADIGM pivotal trial

Reuters
·
May 05

Statement of CDIs on issue - AVR-AVR.O

Reuters
·
May 05